Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Dec 29, 2025
- Accession no.
- 0001231589-25-000013
- Filed
- Dec 29, 2025
- Trade date
- Dec 24, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.64M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $146.03 | +$1,606,330 | 47,781 | Direct | |
| Dec 24, 2025 | Common Stock | SSaleDisposed | −502 | $509.22F2 | −$255,628.44 | 47,279 | Direct | |
| Dec 24, 2025 | Common Stock | SSaleDisposed | −138 | $509.81F3 | −$70,353.78 | 47,141 | Direct | |
| Dec 24, 2025 | Common Stock | SSaleDisposed | −40 | $510.64F4 | −$20,425.6 | 47,101 | Direct | |
| Dec 24, 2025 | Common Stock | SSaleDisposed | −2,877 | $512.59F5 | −$1,474,721.43 | 44,224 | Direct | |
| Dec 24, 2025 | Common Stock | SSaleDisposed | −4,713 | $513.46F6 | −$2,419,936.98 | 39,511 | Direct | |
| Dec 24, 2025 | Common Stock | SSaleDisposed | −2,650 | $514.18F7 | −$1,362,577 | 36,861 | Direct | |
| Dec 24, 2025 | Common Stock | SSaleDisposed | −80 | $516.06 | −$41,284.8 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 9,250 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $508.58 to $509.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $509.60 to $510.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $510.62 to $510.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $511.88 to $512.875. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $512.88 to $513.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $513.89 to $514.88. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.